Welcome to our dedicated page for Microvision SEC filings (Ticker: MVIS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to MicroVision, Inc. (NASDAQ: MVIS) SEC filings, offering a centralized view of the company’s regulatory disclosures. Through these documents, investors can review how MicroVision reports on its lidar hardware and perception software business, its activities in automotive, industrial, and defense-related markets, and its corporate governance and financing arrangements.
Key filings for MicroVision include Form 10-K annual reports and Form 10-Q quarterly reports, which describe the company’s business, risk factors, and financial results. These reports are particularly relevant for understanding MicroVision’s investment in solid-state lidar technologies, its focus on ADAS and autonomous driving, and its efforts in industrial automation and defense tech. Current reports on Form 8-K provide timely updates on material events, such as leadership changes, executive compensation arrangements, board appointments, and the announcement of quarterly results.
MicroVision’s filings also document corporate actions like the appointment of a new Chief Executive Officer, the designation of an Executive Vice Chair, changes in board composition, and transitions in the Chief Financial Officer role. These disclosures help investors track how the company’s leadership and governance structure evolve alongside its strategic focus on autonomy and mobility.
On Stock Titan, MicroVision’s SEC documents are updated in near real time as they are posted to EDGAR. AI-powered summaries assist readers by highlighting the main points in lengthy filings, including key business updates, segment information where provided, and notable risk or governance items. Users can quickly scan 10-K and 10-Q reports, review 8-K announcements about material events, and access other filings while relying on AI-generated explanations to navigate complex regulatory language more efficiently.
MicroVision, Inc. describes a lidar-focused business that remains in heavy investment mode, with substantial losses and a need for ongoing external funding. As of December 31, 2025, the company had an accumulated deficit of $957.3 million and recorded a $95.0 million net loss for 2025.
Results were hit by non-cash charges, including a $10.1 million impairment of perception software from the Ibeo acquisition, a $9.9 million MOVIA L inventory write-down, $2.2 million machinery impairment, and a $3.2 million adverse purchase commitment. Revenue remains concentrated in a few automotive and industrial customers and has recently declined with lost business.
The company is expanding its lidar portfolio through acquisitions of Ibeo assets in 2023 and, in 2026, Scantinel Photonics and Luminar’s worldwide lidar business, adding IRIS and HALO sensors and FMCW technology. This strategy increases operating costs and integration risk while MicroVision relies on securities purchase agreements and senior secured convertible notes to fund operations.
MicroVision warns it expects significant losses and negative cash flow through at least 2026 and will require additional capital beyond the next 12 months. It also discloses a Nasdaq minimum bid-price deficiency, potential dilution from convertible notes and equity issuance, and the risk of secured lenders foreclosing on its bank and securities accounts if it defaults.
MicroVision, Inc. reported fourth quarter and full year 2025 results showing a small revenue base and sizable losses as it transitions from R&D to commercial operations. Revenue was
The company recorded significant non-cash charges, including a Q4 impairment loss on intangible assets of
Management highlighted a strategic shift in early 2026, completing acquisitions of Luminar and Scantinel and beginning shipments on repeatable orders. To strengthen liquidity, MicroVision issued senior secured convertible notes with aggregate principal of
MICROVISION, INC. director Robert Paul Carlile reported the vesting and conversion of restricted stock units into common shares. On this date, 22,007 RSUs were exercised at no cost and settled into 22,007 shares of common stock, bringing his directly held common stock to 350,799 shares.
The footnotes explain that RSUs convert into common stock on a unit-for-share basis without payment and clarify that a prior Form 4 understated the original RSU grant, with vesting now calculated from the corrected 88,028-unit grant.
MICROVISION, INC. director Laura J. Peterson reported the vesting of restricted stock units and their conversion into common shares. On March 2, 2026, 18,005 restricted stock units were exercised on a unit-for-share basis without payment, converting into 18,005 shares of common stock. After this conversion, Peterson directly owned 54,016 shares of MICROVISION common stock. The footnotes explain that RSUs convert into shares without cash outlay at vesting and that a separate RSU grant dated July 22, 2025 is scheduled to vest in four equal quarterly installments, subject to her continued board service.
MicroVision director Peter Schabert reported the vesting of restricted stock units that were converted into common shares. On the transaction date, 22,007 RSUs were distributed without payment and converted into 22,007 shares of common stock. Following this derivative exercise, he directly owns 146,471 common shares. A footnote explains that an earlier Form 4 had misstated the total RSUs granted in June 2025, and this vesting is based on the corrected grant amount.
MICROVISION, INC. director Jada Smith reported the vesting of restricted stock units that converted into common shares. On March 2, 2026, 22,007 RSUs were exercised at $0.00 per unit into 22,007 shares of common stock, bringing her direct common stock holdings to 126,358 shares.
MICROVISION, INC. director Jeffrey A. Herbst reported the vesting of 22,007 restricted stock units, which were converted into an equal number of common shares without payment on a unit-for-share basis. Following this non-cash derivative exercise, he directly holds 230,727 shares of common stock. A prior Form 4 is corrected here to state that the RSU grant on 06/05/2025 was 88,208 units, and the vesting disclosed was calculated from this corrected amount.
MICROVISION, INC. Executive Vice Chair and director Simon Biddiscombe acquired common shares through vesting of restricted stock units. On March 2, 2026, 22,007 RSUs converted into 22,007 shares of common stock on a unit-for-share basis, without payment. Following this RSU conversion, his direct common stock holdings increased to 291,299 shares. The footnotes note that a prior Form 4 had misstated the total RSUs granted on June 6, 2025, and the vesting reported here is based on the corrected grant amount.
MicroVision, Inc. filed a current report to share that it has issued a press release about a video-enabled business update and fireside chat scheduled for February 25, 2026 at 10:00 AM ET with Chief Executive Officer Glen DeVos.
The company notes it has completed two strategic acquisitions in the first two months of 2026, and the event will explore the business rationale for these deals, its near- and long-term roadmap, and its broader strategic vision for the lidar industry.
The interactive webcast, hosted by Hans-Werner Kaas of McKinsey & Company, will be accessible via MicroVision’s investor relations website and archived for future viewing, with investors able to submit questions in advance and during the live event.
MicroVision, Inc. entered into a financing deal with an institutional investor, issuing senior secured convertible notes with an aggregate principal amount of
The structure combines an exchange of an existing 2026 secured convertible note into an approximately
Conversions are limited by a Beneficial Ownership Limitation initially set at